ArticleMicrofluidics and nanofluidics2025
Quantifying and modeling loss of estrogen and progesterone in PDMS-based devices.
Article in Microfluidics and nanofluidics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Development of a Flat-Sheet Membrane Gas Exchange Unit for Oxygen Control in Microfluidic Systems.Micromachines · 2026Article
- A Compact, Standalone & Battery-Powered 3D Organoid-on-Chip System with Programmable Flow Control.bioRxiv : the preprint server for biology · 2026Article
- Organ-on-a-Chip and Microfluidic Plant Cell Culture Systems: The Next Frontier for Controlled Secondary Metabolite Production and Real-Time Metabolomic Monitoring.Plants (Basel, Switzerland) · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An early study on the biological consequences of using polydimethysiloxane (PDMS) for microfluidic cell culture reported that estrogens could be sequestered by PDMS; however, the PDMS interaction parameters of specific hormones have not been reported. Without these parameters, it is not possible to assess whether such sequestration is a problem for a particular device and flow rate combination. Here we quantify chemical-PDMS interactions for a commonly used estrogen and two additional steroid-class hormones: estradiol, aldosterone, and progesterone. We find that aldosterone does not detectably interact with PDMS; estradiol interacts modestly; and progesterone interacts strongly. Based on these measured interactions, we computationally model dynamic dosing protocols based on pulsed/bolus delivery and circadian control. We show that interactions with PDMS can strongly disrupt these dynamic dosing protocols in a chemical-specific and flow-rate-dependent manner. Notably, estradiol-PDMS interactions can have significant impacts under static conditions or low flow rates, but those impacts become negligible at higher flow rates. These results have critical implications for the use of steroid hormones in PDMS-based microfluidic devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.